Cryo-Cell International, Inc.
CCEL
$4.20
-$0.10-2.33%
AMEX
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 31.75M | 31.99M | 32.10M | 31.99M | 31.84M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.75M | 31.99M | 32.10M | 31.99M | 31.84M |
| Cost of Revenue | 7.28M | 7.60M | 7.77M | 7.85M | 11.98M |
| Gross Profit | 24.47M | 24.39M | 24.33M | 24.13M | 19.86M |
| SG&A Expenses | 18.78M | 19.07M | 18.83M | 18.62M | 18.05M |
| Depreciation & Amortization | 763.70K | 772.60K | 642.30K | 483.60K | 568.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.42M | 28.17M | 28.08M | 28.20M | 31.98M |
| Operating Income | 4.33M | 3.82M | 4.02M | 3.79M | -143.30K |
| Income Before Tax | 1.45M | 1.65M | 2.54M | 2.80M | -12.35M |
| Income Tax Expenses | 1.93M | 1.82M | 2.41M | 2.40M | -3.42M |
| Earnings from Continuing Operations | -0.47 | -0.17 | 0.13 | 0.40 | -8.93 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -473.50K | -171.20K | 128.80K | 402.10K | -8.93M |
| EBIT | 4.33M | 3.82M | 4.02M | 3.79M | -143.30K |
| EBITDA | 5.32M | 4.81M | 4.88M | 4.48M | 637.50K |
| EPS Basic | -0.06 | -0.02 | 0.02 | 0.05 | -1.07 |
| Normalized Basic EPS | 0.16 | 0.12 | 0.16 | 0.16 | -0.07 |
| EPS Diluted | -0.07 | -0.03 | 0.01 | 0.05 | -1.07 |
| Normalized Diluted EPS | 0.16 | 0.12 | 0.16 | 0.15 | -0.07 |
| Average Basic Shares Outstanding | 32.29M | 32.29M | 32.33M | 32.52M | 32.74M |
| Average Diluted Shares Outstanding | 32.47M | 32.57M | 32.67M | 32.80M | 33.02M |
| Dividend Per Share | 0.65 | 0.65 | 0.50 | 0.25 | -- |
| Payout Ratio | -1,109.12% | -3,067.58% | 3,137.42% | 502.49% | -- |